Dirk Wössner joins Warburg Pincus Deutschland in Berlin Jan 25, 2024

Berlin, January 25, 2024 –Dirk Wössner has joined Warburg Pincus Deutschland as a Senior Vice President. He will work closely alongside René Obermann and Max Fowinkel who have led the Berlin office since it was opened in 2018.

Before joining Warburg Pincus, Dirk Wössner was CEO of Compugroup Medical, one of Europe’s leading healthcare software providers. Before Compugroup Medical, he held various roles at Deutsche Telekom, most recently as CEO of its German business, and also worked with the Canadian telecommunications provider Rogers Communications. A chemist with a Ph.D. from Humboldt University in Berlin, he began his career at McKinsey.

"Dirk is an experienced manager whom I have known for a long time. He will be a great addition to our effort in Europe", says René Obermann, Co-Head of Europe at Warburg Pincus.

"I am extremely excited about collaborating with the Warburg Pincus team," says Dirk Wössner. "The DNA of Warburg Pincus, with a focus on long-term and sustainable growth, aligns very well with my past management experience, especially in the telecommunications, software, and technology sectors."

Warburg Pincus is one of the world's leading global growth investors with over $84 billion in assets under management. Since its first European transaction in 1983, Warburg Pincus Funds have invested more than $15 billion in over 130 companies across 23 European countries.


Jenna Ward

+44 7570 844 338

Katharina Gebsattel

+49 172 718 68 57

About Warburg Pincus

Warburg Pincus LLC is a leading global growth investor. The Warburg Pincus Funds manage assets exceeding $84 billion with more than 250 companies, highly diversified across phases, sectors, and regions. Warburg Pincus is a seasoned partner for management teams aiming to build companies with sustainable value. Since its establishment in 1966, Warburg Pincus Funds have invested over $113 billion in more than 1,000 companies across more than 40 countries. For further information please refer to or follow us on LinkedIn

Back To News